Factor XIII Val34Leu variant is protective against venous thromboembolism: A HuGE review and meta-analysis

Philip S. Wells; Josdalyne L. Anderson; Dimitrios K. Scarvelis; Steve P. Doucette; France Gagnon

doi:10.1093/aje/kwj179

Factor XIII Val34Leu variant is protective against venous thromboembolism: A HuGE review and meta-analysis

Philip S. Wells, Josdalyne L. Anderson, Dimitrios K. Scarvelis, Steve P. Doucette, France Gagnon

科研成果: 期刊稿件 › 文献综述 › 同行评审

源语言	英语
页（从-至）	101-109
页数	9
期刊	American Journal of Epidemiology
卷	164
期	2
DOI	https://doi.org/10.1093/aje/kwj179
出版状态	已出版 - 7月 2006
已对外发布	是

!!!ASJC Scopus Subject Areas

流行病学

访问文件

10.1093/aje/kwj179

其它文件与链接

引用此

Wells, P. S., Anderson, J. L., Scarvelis, D. K., Doucette, S. P., & Gagnon, F. (2006). Factor XIII Val34Leu variant is protective against venous thromboembolism: A HuGE review and meta-analysis. American Journal of Epidemiology, 164(2), 101-109. https://doi.org/10.1093/aje/kwj179

@article{3f6fd96f1f5e4255ac5e80ee49a7b927,

title = "Factor XIII Val34Leu variant is protective against venous thromboembolism: A HuGE review and meta-analysis",

keywords = "Epidemiology, FXIII Val34Leu, Factor XIII, Genetics, Leucine, Meta-analysis, Valine, Venous thrombosis",

author = "Wells, {Philip S.} and Anderson, {Josdalyne L.} and Scarvelis, {Dimitrios K.} and Doucette, {Steve P.} and France Gagnon",

note = "Funding Information: This work was supported in part by a program grant (PRG5513) and a grant in aid (NA5539) from the Heart and Stroke Foundation of Ontario, and an operating grant (MOP69027) from the Canadian Institutes of Health Research. Dr. Wells is a Canada Research Chair.",

year = "2006",

month = jul,

doi = "10.1093/aje/kwj179",

language = "English",

volume = "164",

pages = "101--109",

journal = "American Journal of Epidemiology",

issn = "0002-9262",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Factor XIII Val34Leu variant is protective against venous thromboembolism

T2 - A HuGE review and meta-analysis

AU - Wells, Philip S.

AU - Anderson, Josdalyne L.

AU - Scarvelis, Dimitrios K.

AU - Doucette, Steve P.

AU - Gagnon, France

N1 - Funding Information: This work was supported in part by a program grant (PRG5513) and a grant in aid (NA5539) from the Heart and Stroke Foundation of Ontario, and an operating grant (MOP69027) from the Canadian Institutes of Health Research. Dr. Wells is a Canada Research Chair.

PY - 2006/7

Y1 - 2006/7

KW - Epidemiology

KW - FXIII Val34Leu

KW - Factor XIII

KW - Genetics

KW - Leucine

KW - Meta-analysis

KW - Valine

KW - Venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=33745631483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745631483&partnerID=8YFLogxK

U2 - 10.1093/aje/kwj179

DO - 10.1093/aje/kwj179

M3 - Review article

C2 - 16740590

AN - SCOPUS:33745631483

SN - 0002-9262

VL - 164

SP - 101

EP - 109

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

IS - 2

ER -

Factor XIII Val34Leu variant is protective against venous thromboembolism: A HuGE review and meta-analysis

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此